发明授权
- 专利标题： Adenoviral vector encoding malaria antigen
- 专利标题（中）： 编码疟疾抗原的腺病毒载体
-
申请号： EP12164331.6申请日： 2008-04-10
-
公开(公告)号： EP2486939B1公开(公告)日： 2017-07-12
- 发明人: Reyes, Arturo , Hill, Adrian , O'Hara, Geraldine , Colloca, Stefano , Cortese, Riccardo
- 申请人： Oxford University Innovation Limited , GlaxoSmithKline Biologicals SA
- 申请人地址： Buxton Court 3 West Way Botley Oxford OX2 0JB GB
- 专利权人： Oxford University Innovation Limited,GlaxoSmithKline Biologicals SA
- 当前专利权人： Oxford University Innovation Limited,GlaxoSmithKline Biologicals SA
- 当前专利权人地址： Buxton Court 3 West Way Botley Oxford OX2 0JB GB
- 代理机构： Dalton, Marcus Jonathan William
- 优先权： GB0706914 20070410; GB0717888 20070913
- 主分类号： C12N15/86
- IPC分类号： C12N15/86 ; C07K14/445 ; C07K16/20 ; C07K14/78 ; A61K39/015
摘要：
The invention provides recombinant adenoviral vectors which are capable of eliciting immunity against the pre-erythrocytic stage of the life cycle of the malaria parasite. In particular, the invention provides a recombinant, replication deficient simian adenoviral vector which encodes an antigen comprising the thrombospondin-related adhesion protein (TRAP), and also immunogenic compositions (e.g. vaccines) comprising the vector and methods of using such compositions.
公开/授权文献
- EP2486939A1 Adenoviral vector encoding malaria antigen 公开/授权日：2012-08-15
信息查询
IPC分类:
